Study of T cells has shown that their antigen receptors
(TCR) recognize a specific combination of MHC molecule and bound peptide (1) (2) (3) . Crystallographic structures for HLAA2 .1 and HLAAw68 .1 revealed the antigen recognition site (4, 5) and sequence comparisons showed that residues lining this groove are the foci for diversity in MHC molecules (6) . Moreover, the substitutions at these positions are clearly the result of positive evolutionary selection (7) (8) (9) . In general it has been reasoned that substitutions within the groove serve to affect the peptides bound by MHC molecules, a concept supported by the observed differences in the pockets of the peptide binding grooves of HLAA2 .1 and HLA-Aw68 .1 and in the shape of the "extra" material they contain (4, 5, 10) . That each individual uses a small number (3-6) of class I molecules to present numerous peptides to a diversity of TCR necessitates that each MHC molecule binds many peptides and engages many TCR . Thus, there are arguments supporting both specificity and degeneracy in MHCpeptide interactions. For class I MHC molecules experimental definition of the specificity of the binding site has proved difficult. This is due to the presence of tightly bound peptides in isolated class I molecules and uncertainty as to the relevance of experimental assays to the mechanism of peptide binding in vivo.
Previously we demonstrated binding of radio-iodinated influenza peptides to solubilized class I HLA molecules in a manner that correlated with the pattern of MHC restriction (11) . We also obtained some evidence for the binding of peptides to nonpresenting MHC molecules . In these solution-based assays the proportion of class I molecules with accessible peptide binding sites was exceedingly low (<1 in 300), a property that significantly limits their applications . Bouillot and colleagues have developed a different assay, in which the binding of radio-iodinated class I HLA molecules to solid-phase peptides is measured (12). Binding was more readily detected than in the solution assay and though discerning quantitative differences in binding, Bouillot et al . (12) concluded that "Peptides which are recognized by cytotoxic T lymphocytes bind not only to the restricting MHC class I molecule but also to other class I molecules:' A striking difference in results obtained with the solid-phase assay compared with those obtained with the solution assay was that up to -25% of the radio-iodinated class I molecules were capable of binding to experimentally offered peptides. This property and the capacity to rapidly screen large numbers of peptides give the solid-phase assay potential for wide applications in the analysis of peptide binding to class I MHC molecules. Here we compare the binding of 5 class I HLA molecules to 64 peptides .
Materials and Methods
Peptides. Peptides were synthesized by a solid-phase method using FMOC or tBOC chemistry. Homogeneity of the peptides was indicated by reverse-phase HPLC.
Isolation ofHLA Molecules. HLA molecules were purified from detergent solubiliwd cell lysates by immunoaffinity chromatography as previously described (13). HLAA2 .1, Aw69, and Aw68 .1 molecules were purified from cell lysates of human lymphoblastoid B cell lines 721 .53 (A2), IDF (Aw69, A26, B18, Bw38), and CIR .Aw68 .1 (a HLA-A,B-negative cell line transfected with the Aw68 .1 gene), respectively, using a monoclonal antiA2, Aw69, Aw68 (CR11 .351) antibody column . HLA-B5 and B44 molecules were purified from cell lysates of B-lymphoblastoid cell line 721 .144 (B5) and C1R .B44 (a B44 transfectant), respectively, using a monomorphic anti-HLA-A,B,C (W6/32) monoclonal antibody column .
Peptide Binding Assay. Direct binding of radiolabeled HLA molecules to peptides precoated onto polystyrene microtiter wells was as described by Bouillot et al . (12) . Briefly, HLA molecules were labeled with 1 mCi of I'll (Amersham Corp., Arlington Heights, IL) by the chloramine T method and fractions containing radiolabeled HLA molecules were collected from a Sephadex G50 column . The HLA molecules were diluted in PBS containing 0 .5% (NP-40), 1% BSA, 0 .02% NaN3, and 1 mM PMSF. Peptides at 1
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Class I Molecules Binding to Solid-Phase Peptides mg/ml were plated in duplicates in polystyrene microtiter plates (Dynatech, Alexandria, VA) . Plates containing 10 141 peptides per well were incubated for 16 h at room temperature and washed twice with 0.1% BSA in PBS. Unoccupied sites were saturated with 1% BSA in PBS for 1 h . The plates were washed three times and radiolabeled HLA molecules were added and placed at room temperature for 18 h . The plates were then washed three times and radioactivity bound per well was measured by direct counting in a gamma counter. Detection ofHLA by mAbs . HLA molecules bound on peptideprecoated plates were detected by anti-HLA mAb and radiolabeled rabbit anti-mouse antibodies as secondary and tertiary reagents. HLA molecules were added to peptide precoated plates for 18 h at room temperature then washed three times with 0 .1% BSA in PBS followed by incubation with 1% ovalbumin in PBS for 30 min at 4°C. After incubation, the microwells were washed twice and anti-HLA mAbs (250 jig/ml) were added to each well and placed at 4°C for 45 min. At that time, the microwells were then washed three times with 0.1% BSA in PBS and radioiodinated rabbit anti-mouse F(ab')2 were added to each well at 600,000 cpm/well . The plates were placed at 4°C for 45 min, then washed three times and radioactivity bound per well was counted.
Comparison of the crystallographic structures ofHLAA2.1 and HLAAw68.1 revealed differences in the detailed architec- ture of the peptide binding groove, indicating that these molecules would exhibit distinctive peptide binding specificity (5) . In an attempt to identify discriminating peptides we tested 64 peptides for binding to HLAA2.1 and HLAAw68.1 using the solid-phase assay ofBouillot et al. (12). Binding to HLA Aw69, which has a hybrid peptide binding groove (at derived from HLAAw68 .1 and (X2 derived from HLAA2.1) and to HLAB44 and HLAB5 was also assessed. The peptides tested had sequences derived from various viral antigens, HLAA,B,C heavy and light chains and clathrin light chains (Fig. 1) . consensus GSNSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRMEPRAPWIEQEGPEYWDRETQIVKAQSQTDRESLRTLRGYYNQSEA  1  10  20  30  40  50  60  70  80  90   o2 domain   100  110  120  130  140  150  160  170  180  consensus GSHTLQRMYGCDVGPDGRLLRGYHQYAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAARVAEQLRAYLEGTCVEWLRRYLENGKETLQRA A2 . 190  200  210  220  230  240  250  260  270 Fifteen of the 64 peptides bound to HLAA2.1 at levels >10-fold of background, 15 peptides gave binding twofold above background levels and 34 were negative ' (Fig. 2 A) . Positively binding peptides were found among the HLA peptides and the viral peptides, but not among the clathrin peptides . The lack of HLA binding to the clathrin peptides was not due to poor absorption of peptides to the microtiter plates as many of these peptides bind to specific anti-clathrin monoclonal and polyclonal antibodies in similarly configured assays (14) . Thus, there is, as previously demonstrated (12), discrimination between peptides in this assay . Calculation also shows that up to 30% of the total input of radio-iodinated HLA-A2 .1 molecules can bind to solid-phase peptide . Among the strongly binding peptides is that corresponding to residues 57-68 of the influenza matrix peptide (F1u .M57-68) and the binding of HLA-A2 .1 to this peptide we observed is comparable to that reported by Bouillot et al. (12) . This peptide has repeatedly been shown to be presented to influenza specific CTL by HLAA2 .1 and HLAAw69 (15). In addition, Gotch et al . (16) have tested peptide analogues for their capacity to substitute for F1u.M57-68 and have identified positions at which substitution prevents presentation to specific CTL . The pattern of binding of HLAA2 .1 to these analogue peptides observed in the solid-phase assay closely correlates with the pattern of sensitization observed by Gotch and colleagues (Gotch, A, and McMichael, A . J ., unpublished data, personal communication), showing that among this highly related set of peptides, binding correlates with presentation (Fig. 2 B) with the exception that peptides E63, Y63, and F63 bound in the solid-phase assay and were not recognized by CTL and did not inhibit presentation of the matrix peptide by HLAA2 . 93 4 Class I Molecules Binding to Solid-Phase Peptides Figure 3 . The amino acid sequences of the al, a2, and a3 domains of the five HLA-A and -B molecules studied here. The standard one-letter amino acid code is used . A dash indicates that a residue is identical to that found in the consensus sequence.
------S-TNT--Y--N---ALR-------B51 ----------AM--------------------------------T-----------------N---F-TNT--Y--N--IALR-------

----V---------S-W-F-----------------K----------M---T-KH-----H--__--------------------------T
Aw69 ----V---------S-W-F-----------------K----------M---T-KH-----H------------------------------T
Aw68 .1 ----I-M-------S---F----R-D----------K----------M---T-KH-----H----W-------------------------T B44 .2 ---II------------------D-D--------------S------------------------D--__--L---S---------------B51 ---II-----------------HN----------------S--------------------E----------L-------H-----------
-A----M---AV------------S-------------------------------G-------------Q---------------------
Aw69 -A----M---AV------------S-------------------------------G-------------Q-------------__------
Aw68 .1 -A----M---AV------------S-------------------------------G-----V-------Q---------------------
B44.2 ----------------V---------------------------------------------------------------------------
B51 -----------V--------------------------------------------------------------------------------consensus DPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRW
It was therefore surprising that no significant discrimination between five different MHC molecules was observed in this binding assay ; the pattern of binding of HLAA2.1 to the 64 peptides was mimicked by HLAAw68.1, Aw69, B5, and B44 (Fig. 2) . Thus every peptide that bound to one HLA molecule bound to the other four; peptides that failed to bind to one HLA molecule did not bind to the other four. Even when the levels of binding of different peptides to the five HLA molecules were compared, there were no significant differences that could be ascribed to "HLA type."
These results clearly challenge the hypothesis that variation between class I MHC molecules, which is mainly found in the peptide binding groove, acts significantly to alter the peptide binding specificity. The five HLAA,B molecules studied here show considerable variation in the residues that point into the groove, between 5 and 17 amino acid differences (Fig . 3) , and yet their pattern of peptide binding appears identical .
This raised the possibility that it was denatured HLA molecules, or an iodinated contaminant in the HLA preparations, that was binding the peptides. To address this question we separated radio-iodinated HLAA2 on a column of a W6/32, a mAb that only binds to native Dam-associated molecules, and measured the binding to peptides of the bound and the unbound radioactivity. All peptide binding activity of the 125 1-HLAA2 preparation was removed by passage over the W6/32 column, showing that the observed peptide binding was due to 02m-associated HLAA2 heavy chains and not to free heavy chains or a contaminant . This conclusion was confirmed by the recovery of peptide binding activity by elution of material bound to the W6/32 column. Moreover, only a fraction (1/10) of the radioactivity was needed to achieve binding comparable to the level obtained with unfractionated radiolabeled HLAA2 (Table 1) .
A further source of potential artefact is modification of the HLA molecules by the iodination reaction . The peptide binding groove of MHC molecules is characterized by a number of strategically placed tyrosine residues (4) and it is possible that their iodination could alter the combining site specificity to give a degenerate pattern of peptide binding. To circumvent this issue we developed a modified assay in which the binding of noniodinated HLA molecules to platebound peptides was measured using specific anti-HLAA,B mouse mAbs and radic iodinated anti-mouse Ig (Fig. 4) . This indirect assay gave similar patterns of peptide binding to those seen in the direct assay and equivalent results were obtained with six mAbs directed against different epitopes of HLAA,B molecules ; results obtained with W6/32 and A2 .1 mAb are shown (Fig. 4 A) . Protein modification due to radio-iodination is therefore not the source of the degenerate binding .
Discussion Bouillet et al . (12) previously analyzed the binding of radioiodinated HLAA2 .1, HLA1137, and HLAB27 to solid-phase peptides . Peptides that were known to be antigenic for T cells bound to their appropriate restriction element, but although some quantitative differences were observed, these authors found that peptides binding to one class I molecule tended to bind to others. In three cases where direct comparison can be made, the binding of HLAA2 .1 to influenza nuclear protein peptide FLU.NP335-349, influenza matrix protein peptide FLU.M57-68, and HIV gag protein peptide HIV gag.265-279, we obtain comparable results to Bouillot et al. Furthermore we find the assay robust, highly reproducible, and suitable for screening large numbers of samples .
Comparison of the binding of the same MHC molecule to different peptides showed specificity that correlated with precoated with peptides and presaturated with 1% BSA. The reaction plates were placed at room temperature for 18 h then washed three times, and unbound sites were saturated with 1% ovalbumin in PBS. Monomorphic anti-HLA antibody W6/32. at 250 leg/ml was added to each well in 50 ul and incubated at 4°C for 45 min.: The microwells were washed three times and 1251-labeled rabbit anti-mouse F(ab')2 were added to each well for an additional 45 mina Radioactivity bound per well was measured by direct counting of well washed to remove excess radioactivity. presentation to T cells . In contrast we found no significant differences in the patterns ofpeptide binding of five different class I molecules . Bouillot et al. were able to discern some quantitative differences in titration experiments. In this study peptides were plated at 1 mg/ml, a concentration that for known antigens gave maximal binding, and this protocol may have served to reduce the discriminating capacity of the assay. Nevertheless it is clear from our results and those ofFrelinger et al. (17) with this assay that it is hard to argue for a profound effect of MHC polymorphism on the binding ofpeptides to HLAA,B molecules . The critical issue is whether this is a true reflection of the specificity of peptide binding by class I molecules or an artefact of the assay. Trivial artefacts have been ruled out . The binding is clearly the product of 02m-associated HLAA,B heavy chains and is not dependent upon radioiodination . Conformational antigenic determinants of the HLAA,B molecules are preserved on binding to solid-phase peptides. In addition we know that binding does not require the presence ofdetergent or the hy-Papain solubilized and genetically engineered, secreted HLA molecules give similar binding to the detergent solubilized product . These results combined with the peptide specificity and its correlation with T cell reactivity argue for binding being within the peptide binding groove. That the binding grooves of a much greater proportion of HLAA,B molecules are accessible to solid-phase peptides than to peptides in solution suggests that interactions at the solid phase facilitate either displacement of the endogenous peptide or the simultaneous binding of the endogenous peptide and the experimentally offered peptide. This might involve nonphysiological interactions between the class I molecules and plastic that loosen up the structure and thereby reduce the specificity ofthe combining site. Alternatively the plastic surface might mimic conditions that MHC molecules encounter in vivo and which contribute to their function .
